Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Rosy Reynolds und 9 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences, University of Bristol, Bristol BS8 2PS, UK. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Anti-Bacterial Agents, Community-Acquired Infections, Drug Resistance, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Society for Antimicrobial Chemotherapy.
Abstract (Originalsprache)
Objectives
The BSAC Respiratory Surveillance Programme examined resistance trends among Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired lower respiratory tract infection (CA-LRTI).
Methods
Quotas of isolates were sought per collecting site from 1999/00 to 2018/19; an annual October start date captured winter infection peaks within single years. MIC testing was by BSAC agar dilution. β-Lactamase detection with nitrocefin and pneumococcal serotyping by classical methods or WGS.
Results
Resistances were uncommon, except that β-lactamases occurred in c. 20% of H. influenzae from 2012/13 following earlier rises, and in >90% of M. catarrhalis throughout. Only 0.11% (12/10881) of S. pneumoniae were fully resistant to penicillin; co-amoxiclav inhibited 97.8% of 13526 H. influenzae and >99.9% of 6309 M. catarrhalis isolates. Cefotaxime inhibited >99% of all isolates at breakpoint, as did relevant fluoroquinolones in the fewer years tested. Tetracycline inhibited >98% of H. influenzae and M. catarrhalis and 85% of S. pneumoniae. Significant shifts were: (i) fluctuating resistances to tetracyclines, macrolides and penicillin in pneumococci, reflecting serotype replacements; (ii) expansion, from 2012/13, in the proportion of H. influenzae with β-lactamase-independent amoxicillin/co-amoxiclav resistance; and (iii) increasing high-level amoxicillin resistance (MIC > 64 mg/L) among β-lactamase-positive H. influenzae. MIC differentials were seen for cephalosporins between β-lactamase-positive and β-lactamase-negative M. catarrhalis, greatest (512-fold) for ceftaroline.
Conclusions
CA-LRTI remains eminently treatable, yet shifts are occurring in the serotypes of S. pneumoniae most associated with resistance and in the nature of amoxicillin resistance in H. influenzae. β-Lactamase-related cephalosporin MIC differentials for M. catarrhalis are striking but their clinical significance remains uncertain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Population Health Sciences, University of Bristol, Bristol BS8 2PS, UK.
- British Society for Antimicrobial Chemotherapy, 53 Regent Place, Birmingham B1 3NJ, UK.
- Hammerfest, Arrow Lane, Hartley Wintney RG27 8LR, UK.
- Antimicrobial Resistance and Healthcare Associated Infections Reference Unit, UK Health Security Agency, Colindale, London NW9 5EQ, UK.
- Medical Affairs, MSD (UK) Limited, 120 Moorgate, London EC2M 6UR, UK.
- Scientific Affairs, Shionogi B.V., Fifty Paddington, 50 Eastbourne Terrace, Paddington W2 6LG, UK.
ORCID-Profile: Shazad Mushtaq, Christopher Longshaw
Förderung
- British Society for Antimicrobial Chemotherapy
Zitieren
APA
Reynolds, R., Felmingham, D., Mushtaq, S., Horner, C., Chaudhry, A., Adkin, R., Allen, M., Longshaw, C., Parcell, B. J., & Livermore, D. M. (2025). Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf252
Vancouver
Reynolds R, Felmingham D, Mushtaq S, Horner C, Chaudhry A, Adkin R, et al. Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf252
BibTeX
@article{Reynolds2025,
author = {Reynolds, Rosy and Felmingham, David and Mushtaq, Shazad and Horner, Carolyne and Chaudhry, Aiysha and Adkin, Rachael and Allen, Michael and Longshaw, Christopher and Parcell, Benjamin J and Livermore, David M},
title = {Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf252}
}
EUVIMED